JME
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Journal of Molecular Endocrinology (1989) 2 3-9    DOI: 10.1677/jme.0.0020003
© 1989 Society for Endocrinology

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (198)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Clark, A. J. L.
Right arrow Articles by Rees, L. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Clark, A. J. L.
Right arrow Articles by Rees, L. H.

Pro-opiomelanocortin mRNA size heterogeneity in ACTH-dependent Cushing's syndrome

A. J. L. Clark, P. M. Lavender, G. M. Besser and L. H. Rees

As an approach to understanding the abnormalities of pro-opiomelanocortin (POMC) gene regulation in human ACTH-secreting tumours, we have analysed the POMC mRNA content of nine such tumours using the Northern blot technique. Most of the tumours and normal human pituitary contained easily detectable quantities of POMC mRNA. The length of this message in most tumours was similar to, or slightly larger than, that in the normal pituitary (1150-1200 bases). Ribonuclease H studies suggested that the origin of any size heterogeneity was a longer poly(A) tail in the tumour RNA. Some tumours, however, expressed a short POMC mRNA (800 bases) which may lack the first two exons of the POMC gene as has been described. A third POMC mRNA size variant (1500 bases) was also seen in low levels in two cases, and as the principal mRNA species in one case. Primer extension and S1 nuclease protection studies suggested that most transcripts in the tumours analysed originated from the conventional promoter, and thus the use of an alternative promoter is not an adequate explanation for the expression of this gene in ectopic ACTH-secreting tumours.




This article has been cited by other articles:


Home page
Am. J. Respir. Cell Mol. Bio.Home page
Y. Ueda, S. Bandoh, J. Fujita, M. Sato, Y. Yamaji, and J. Takahara
Expression of Nerve Growth Factor-Induced Clone B Subfamily and Pro-opiomelanocortin Gene in Lung Cancer Cell Lines
Am. J. Respir. Cell Mol. Biol., June 1, 1999; 20(6): 1319 - 1325.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1989 by the Society for Endocrinology.